Preoperative MRSA Decolonization Regimen
For MRSA carriers undergoing surgery, use intranasal mupirocin 2% twice daily for 5 days combined with chlorhexidine gluconate (CHG) 4% body wash daily, completing the regimen 1-2 weeks before surgery. 1
Strength of Recommendation by Surgery Type
The 2024 European Society of Clinical Microbiology and Infectious Diseases guidelines provide clear, evidence-based direction:
Strong Recommendation (Cardiac & Orthopedic Surgery)
- Mupirocin 2% nasal ointment twice daily for 5 days
- Combined with chlorhexidine gluconate soap 40 mg/mL (4%) daily baths
- This carries a strong recommendation with moderate certainty of evidence for cardiac and orthopedic procedures 1
Conditional Recommendation (Other Surgeries)
- Same regimen (mupirocin + CHG) but with conditional recommendation and low certainty of evidence for other surgical procedures 1
Specific Protocol Details
Timing
- Complete decolonization 1-2 weeks before surgery 1
- If the 5-day course cannot be completed preoperatively, finish it postoperatively 1
- For elective surgery, consider postponing the procedure to complete decolonization if feasible and safe 1
High-Risk Populations Requiring Special Attention
- Immunocompromised patients
- Procedures involving prosthetic material (joint replacements, cardiac implants)
- These patients likely benefit most from decolonization due to elevated risk of Staphylococcus aureus surgical site infections 1
Evidence Supporting This Approach
The guidelines are based on nine RCTs conducted between 2002-2020, with the landmark Bode et al. study demonstrating:
- 59% reduction in S. aureus healthcare-associated infections (RR 0.41,95% CI: 0.22-0.76)
- 79% reduction in deep surgical site infections from any pathogen (RR 0.21,95% CI: 0.07-0.62) 1
Supporting research shows:
- 95.2% decolonization success rate with this protocol 2
- Cardiac surgery patients had 47% reduction in MRSA colonization and 42% reduction in surgical site infections with screening and targeted decolonization 3
- Total joint arthroplasty studies demonstrate effective eradication of MRSA colonization (from 4.6% to 0%) 4
Important Caveats
When MRSA Carriers Still Have Worse Outcomes
Despite proper decolonization, MRSA-positive patients undergoing total joint arthroplasty still experience:
- Longer hospital stays
- Higher readmission rates (30-day and 90-day)
- Higher septic and aseptic revision rates 5
This means: Counsel MRSA carriers that decolonization reduces but does not eliminate their elevated surgical risk.
Screening Considerations
- The guidelines suggest screening for MSSA/MRSA before elective cardiac and orthopedic surgery according to local epidemiology 1
- Screening alone without decolonization is not effective 1
- Universal decolonization without screening should be applied cautiously due to mupirocin resistance concerns 1
Antimicrobial Stewardship
- Monitor for mupirocin resistance in colonizing isolates 1
- Base implementation on local prevalence of S. aureus colonization and infection 1
- Maintain standard infection control measures (hand hygiene, surgical technique) as these remain paramount 1
Additional Perioperative Considerations
For MRSA-positive patients specifically, some centers add:
- Intravenous vancomycin as part of surgical prophylaxis (in addition to standard cefazolin) 5, 3
- Contact isolation precautions perioperatively 3
The evidence shows longer duration of preoperative decolonization therapy correlates with decreased postoperative MRSA colonization (OR 0.73,95% CI: 0.53-1.00) 3, reinforcing the importance of completing the full 5-day course well before surgery.